Search Results 51-60 of 5437 for edward loftus

  1. A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) - Mayo Clinic

    Edward Loftus, M.D.. Contact information: IBD Clinical Research Unit. (507) 284-5908. Closed for enrollment. More information. Publications. Publications are ...

  2. Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease - Mayo Clinic

    Participating Mayo Clinic locations ; Rochester, Minn. Mayo Clinic principal investigator. Edward Loftus, M.D.. Closed for enrollment ...

  3. A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  4. A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  5. A Study to Evaluate Remicade (Infliximab) for the Prevention of Recurrence in Crohn's Disease Patients Undergoing Surgical Resection and are at an Increased Risk of Recurrence - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  6. Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  7. Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  8. SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  9. A Study of the Effectiveness and Safety of Vedolizumab Compared to Adalimumab for Participants with Ulcerative Colitis - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  10. A Study to Evaluate the Safety and Effectiveness of Ustekinumab Induction and Maintenance Therapy in Participants with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...